BPC-157 dosing chart (mg to units)
BPC-157's PinPoint entry brings together a 5 mg catalog vial and a short, low-confidence level model. The library classifies it as a peptide with Limited human research status. Its amount chart uses the vial total directly, including a 0.1 mg first row.
Vial concentration
Water mL is treated as final solution mL in these columns.
| Vial contents | 1 mL water | 2 mL water | 3 mL water |
|---|---|---|---|
| 5 mg | 5 mg/mL20 U-100 units per mg | 2.5 mg/mL40 U-100 units per mg | 1.6667 mg/mL60 U-100 units per mg |
Vial source: PinPoint/Data/CompoundLibrary.swift, line 467, the BPC-157 entry. One documented amount is available.
Amount to units
Example amounts (arithmetic only, not doses).
| Amount (mg) | 5 mg + 1 mL | 5 mg + 2 mL | 5 mg + 3 mL |
|---|---|---|---|
| 0.1 mg | 2 units | 4 units | 6 units |
| 0.25 mg | 5 units | 10 units | 15 units |
| 0.5 mg | 10 units | 20 units | 30 units |
| 1 mg | 20 units | 40 units | 60 units |
| 2.5 mg | 50 units | 100 units | 150 unitsover one syringe |
Cited amounts
| Amount (mg) and source context | Frequency as stated | Route as stated | 5 mg + 1 mL | 5 mg + 2 mL | 5 mg + 3 mL | Source |
|---|---|---|---|---|---|---|
| 10 mgTwo-person pilot: 10 mg in 250 mL saline over 1 hour; source infusion volume differs from these arithmetic columns. | One infusion on day 1 | Intravenous infusion | 200 unitsover one syringeexceeds vial contents | 400 unitsover one syringeexceeds vial contents | 600 unitsover one syringeexceeds vial contents | BPC-157 intravenous pilot, Alternative Therapies (2025)Peer-reviewed studyRetrieved 2026-10-05 |
| 20 mgTwo-person pilot: 20 mg in 250 mL saline over 1 hour; source infusion volume differs from these arithmetic columns. | One infusion on day 2 | Intravenous infusion | 400 unitsover one syringeexceeds vial contents | 800 unitsover one syringeexceeds vial contents | 1200 unitsover one syringeexceeds vial contents | BPC-157 intravenous pilot, Alternative Therapies (2025)Peer-reviewed studyRetrieved 2026-10-05 |
How to read this chart
Find the concentration column. Divide the amount by that concentration. Multiply the mL value by 100 for U-100 units. Match the amount units before dividing.
units = amount ÷ (vial mg ÷ water mL) × 100
Amount and volume
One mg equals 1,000 mcg; 100 U-100 units equals 1 mL. Concentration connects amount to volume. Read the full conversion guide.
A reference measured in minutes
The BPC-157 half-life field is 0.25 hours, equivalent to 15 minutes. PinPoint's source note traces that number to preclinical intravenous data rather than a characterized human response. A model with such a short timescale places most of an individual event's shape close to its timestamp; a day-wide summary can make that detail difficult to see. The stored number describes the app's elimination reference. It is separate from the once-daily or twice-daily schedule text also present in the entry.
Different routes need their own log context
The current app library includes subcutaneous, intramuscular, oral, and sublingual routes for BPC-157. Its comments discuss oral and buccal forms separately from the injection references. That breadth explains why a compound name alone does not completely describe a logged event: the selected route supplies additional context to the model. The page's U-100 table addresses the compounded-vial volume calculation. An oral or sublingual record can share the molecule's name without turning a syringe-volume table into a conversion for those other delivery forms.
What the low-confidence model contains
BPC-157 carries a base bioavailability coefficient of 0.165 and a peak-time input of 0.5 hours. Written another way, those fields are 16.5% and 30 minutes. The library explicitly flags its pharmacokinetics as low confidence and describes the underlying reference as preclinical. These numerical fields let PinPoint draw a tracking estimate, but their presence does not convert the limited evidence into a measured human curve. The app's one-line description centers that evidence limitation instead of attaching a clinical outcome to the peptide.
Working from the documented 5 mg vial
The package amount comes from a supplier catalog listing 5 mg per vial. Dividing by 50, 20, 10, 5, and 2 gives the five example amounts: 0.1, 0.25, 0.5, 1, and 2.5 mg. At a final solution volume of 2 mL, the middle 0.5 mg row occupies 0.2 mL, or 20 U-100 units. This row represents a tenth of the vial. Its volume becomes 0.1 mL in the 1 mL column and 0.3 mL in the 3 mL column, preserving the same fraction.
Questions about the conversion
What concentration is BPC-157 at 5 mg in 1 mL?
5 mg divided by 1 mL is 5 mg per mL. That volume spans 100 U-100 syringe units.
How does 2 mL change the concentration of this BPC-157 vial?
5 mg divided by 2 mL is 2.5 mg per mL, half the concentration in the 1 mL column.
What does the 3 mL column mean for BPC-157?
5 mg divided by 3 mL is approximately 1.6667 mg per mL. The full 3 mL volume corresponds to 300 U-100 units.
How many units is 0.5 mg of BPC-157 from this vial in 2 mL?
0.5 mg divided by 2.5 mg per mL is 0.2 mL, or 20 U-100 units.
How many units is the 10 mg cited amount of BPC-157 from a 5 mg vial in 2 mL?
The arithmetic is 10 mg ÷ 2.5 mg/mL × 100 = 400 U-100 units (4 mL). The amount is cited in BPC-157 intravenous pilot, Alternative Therapies (2025). Two-person pilot: 10 mg in 250 mL saline over 1 hour; source infusion volume differs from these arithmetic columns. This exceeds the vial contents. This exceeds one 1 mL syringe.
Track your calculations in the app
PinPoint for iOS brings vial setup, unit conversion, dose logs, site rotation, and protocol tracking together. Enter vial size and water volume for concentration and syringe units, then log injections with compound, dose, site, and pain level.
Get PinPoint on the App Store